Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.
Jan 31, 2024
0
0
The golden road to pharmaceutical riches can quickly become a rocky wilderness trail. Chemical compounds that hit a target in the lab often fall short in human studies.
Dec 13, 2023
0
18
Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.
Oct 4, 2023
0
12
Arizona State University will establish its own medical school amid an ongoing shortage of health care workers across the state.
Jun 2, 2023
0
2
With the only cure for liver cancer often being a transplantation, scientists are honing the selection of patients for this life-saving surgery and growing replacement livers in a lab.
Jan 10, 2023
0
2
For years, Joe Connolly watched his mother, aunt and grandmother struggle with a series of health problems.
Jul 21, 2022
0
21
An impressive number of brain pathologies are closely linked to major cerebrovascular defects, which are currently impossible to treat due to a lack of drugs. The discovery by researchers from the ULB Neuroscience Institute ...
Feb 18, 2022
0
312
Indonesia's failure to reduce the number of COVID-19 cases nine months after declaring its first cases in March reflects its slow and poor responses to the spread of COVID-19 pandemic. Its handling of the virus has taken ...
Dec 4, 2020
0
0
The World Bank's Pandemic Emergency Financing Facility (PEF) – set up to ensure swift funding to countries and agencies responding to pandemic outbreaks of disease—does not deliver on this promise, new research from the ...
Oct 18, 2019
0
26
CarePartners Plus, a healthcare software firm based in Horsham, Pa., wants to get its product into consumers' hands as soon as possible.
Oct 10, 2019
0
1
An investor is any party that makes an investment.
The term has taken on a specific meaning in finance to describe the particular types of people and companies that regularly purchase equity or debt securities for financial gain in exchange for funding an expanding company. Less frequently, the term is applied to parties who purchase real estate, currency, commodity derivatives, personal property, or other assets.
The term implies that a party purchases and holds assets in hopes of achieving capital gain or cash flow, not as a profession or for short-term income.
This text uses material from Wikipedia, licensed under CC BY-SA
